From the AEAStat staff:
The U.S. Government Accountability Office (GAO) invites nominations to the Medicare Payment Advisory Commission (MedPAC) by February 14, 2020.
https://www.federalregister.gov/documents/2020/01/15/2020-00521/request-for-medicare-payment-advisory-commission-medpac-nominations
MedPAC is an agency of Congress whose mandate is to analyze access to care, quality of care, and other issues affecting Medicare and to advise Congress on payments to health plans participating in the Medicare Advantage program and providers in Medicare’s traditional fee-for-service program. MedPAC was established by the Balanced Budget Act of 1997 (42 U.S.C. 1395b-6 (2008)).
The commission's 17 members serve 3-year terms (from May 1 to April 30), with the terms subject to renewal. The law requires that the commission comprise a mix of individuals with expertise in the financing and delivery of health care services and have a broad geographic representation. Commissioners include physicians and other health professionals, employers, third-party payers, researchers with a variety of health-related expertise, and representatives of consumers and the elderly.
The MedPAC website is
http://www.medpac.gov/
A list of current members and their terms is at
http://www.medpac.gov/-about-medpac-/commission-members
The text of 42 USC 1395b-6 establishing MedPAC is at
https://www.law.cornell.edu/uscode/text/42/1395b-6 Subsection (c)(2) specifies the qualifications of MedPAC members:
(2)Qualifications
(A)In general
The membership of the Commission shall include individuals with national recognition for their expertise in health finance and economics, actuarial science, health facility management, health plans and integrated delivery systems, reimbursement of health facilities, allopathic and osteopathic physicians, and other providers of health services, and other related fields, who provide a mix of different professionals, broad geographic representation, and a balance between urban and rural representatives.
(B)Inclusion
The membership of the Commission shall include (but not be limited to) physicians and other health professionals, experts in the area of pharmaco-economics or prescription drug benefit programs, employers, third-party payers, individuals skilled in the conduct and interpretation of biomedical, health services, and health economics research and expertise in outcomes and effectiveness research and technology assessment. Such membership shall also include representatives of consumers and the elderly.
(C)Majority nonproviders
Individuals who are directly involved in the provision, or management of the delivery, of items and services covered under this subchapter shall not constitute a majority of the membership of the Commission.
